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 OA license.supported by gluconeogenesis [1]. Additionally, during tick embryo
development, the transition from syncytial to cellular blastoderm
represents not only a decisive moment in embryo formation, but
also a shift in embryo metabolism in order to reduce the consump-
tion of glucose reserves coupled with increased protein degradation
to sustain gluconeogenesis [1,2]. Interestingly, cellular processes
that take place before and after Aedes aegypti mosquito embryo
germ band retraction are known to greatly affect glucosemetabolism
as well [3].
Globally, ectoparasites have medical, veterinary and economic im-
portance, primarily due to their ability to transmit a diverse range of
pathogens, and also due to the toxic and immunosuppressive compo-
nents in their saliva [4]. Thus, elucidating the physiological processes
of disease vectors is central to the development of new control
methods. The establishment of tick cell lines provided a powerful tool
for studying vector-pathogen interactions at cellular level and also to
understand the mechanisms behind pesticide resistance [5–8]. A better
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these cells may contribute to the discovery of novel pathways that can
be targeted in the design of anti-tick control measures [9,10].
Cell metabolism, growth, survival and replication are dependent on
extracellular signals that require receptor-mediated transduction to in-
tracellular components [11]. Growth factors responsive machinery co-
ordinates such events in a mechanism whose components are highly
conserved in metazoan species: the phosphoinositide 3-kinase (PI3K)/
AKT (also known as protein kinase B, PKB) pathway [12,13]. In mam-
mals, the activation of PI3K/AKT pathway facilitates glucose uptake in,
but not limited to insulin-responsive tissues [14–16]. Normally, PI3K
is activated upon stimulation of membrane receptor tyrosine kinase
(RTK), G protein-coupled receptors (GPCRs) and cytokines receptors
via extracellular growth factors [17]. Activated PI3K generates phos-
phatidylinositol lipidswhich lead to recruitment and activation of addi-
tional kinases, especially AKT. AKT activation is fully accomplished by
phosphorylation at two speciﬁc residues and represents a node of
major regulation of the many cellular effects of insulin/insulin-like
growth factors signaling pathway (ISP) [18–21]. A diversity of AKT sub-
strates is associatedwith the promotion of cell survival, inhibition of ap-
optosis, stimulation of glycogen, protein and lipid synthesis, inhibition
of gluconeogenesis and promotion of glycolytic enzymes [12].
Previous studies reported the immunodetection of insulin-like pro-
teins in tick synganglion [22–24]. Although such endogenous peptides
remain to be identiﬁed, IGF-binding proteins (IGFBP) have been charac-
terized in ticks before, suggesting modulation of the insulin/IGF path-
way to complete bloodmeal acquisition [25]. Moreover, the BME26
cell line was shown to be responsive to the addition of exogenous insu-
lin that ismarked by an increase in glycogen content, and this effectwas
completely abolished in the presence of PI3K inhibitors [26]. Insulin ad-
dition alone was also able to alter the relative transcription of PI3K reg-
ulatory subunit p85. Recent identiﬁcation of AKT in parthenogenic
Haemaphysalis longicornis ticks points to its role in blood feeding and
cell and organ growth in adult stages [27].
One of the target proteins negatively regulated by the PI3K/AKT
pathway is glycogen synthase kinase 3 (GSK3), a conserved eukary-
otic serine/threonine kinase, which is inhibited by phosphorylation
at Ser21 (GSKα) or Ser9 (GSKβ) positions by AKT [28]. GSK3 is
reported to affect several cellular functions such as cell cycle, gene
transcription, apoptosis and development, besides its role in carbo-
hydrate metabolism, where it inhibits glycogen synthase by phosphor-
ylation. Tick GSK3 exists only in one isoform, and it has been found that
its enzymatic activity is inversely related to embryo glycogen content
[29]. Similarly, mosquito GSK3 activity also varied oppositely with gly-
cogen content during initial stages of A. aegypti embryo development
[3]. Importantly, GSK3 activity is also necessary for tick oviposition
and egg viability, as evidenced from both chemical inhibition and
adult gene knockdown [30].
Although GSK3 role in oviposition and embryo development has
been characterized in other models [31], the upstream regulators that
control tick metabolism are unknown. Herein, we report the identiﬁca-
tion and cloning of an AKT from R. microplus, and characterized its role
in glycogen metabolism and cell viability as an upstream regulator of
GSK3 in BME26 cells using both RNA interference (RNAi) and chemical
inhibition methods. The antagonistic roles observed for AKT and GSK3
strongly suggest that such a signaling axis is conserved in tick embryos.
2. Experimental procedures
2.1. Chemicals
The AKT inhibitor 10-DEBC {10-[4′-(N,N-Diethylamino)butyl]-2-
chlorophenoxazine hydrochloride} and PI3K inhibitor, wortmannin,
were purchased from Tocris Bioscience (Ellisville, MO, USA).
LY294002, an additional inhibitor for PI3K was purchased from
Calbiochem (San Diego, CA, USA). GSK3 inhibitor, alsterpaullone{9-Nitro-7, 12-dihydroindolo [3,2-d][1]benzazepin-6(5H)-one}, Hoechst
33342, Propidium iodide, MTT [3-(4,5-Dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide], Leibovitz's 15 culture medium
and α-amiloglucosidase were purchased from Sigma Chemical Co.
(St. Louis, MO, USA). Fetal bovine serum (FBS) was obtained from
Nutricell Nutrientes Celulares (Campinas, SP, Brazil). Other reagents
and chemicals used were of analytical grade and purchased locally.
2.2. BME26 cell line
Cells were maintained as previously described [32]. Attached cells
from conﬂuent ﬂasks (25 cm2) were resuspended in fresh complete
medium using a 22-gauge needle with bent tip ﬁtted to a 5-mL plastic
syringe. Cells were passaged every 3–4 weeks, and the medium
replaced weekly. Culture density was determined using a Neubauer
hemocytometer and cell viabilitywas determined by trypan blue exclu-
sion (0.4%, Sigma) technique. Two weeks prior to their use in experi-
ments, synchronized cells were prepared by transferring 1×107 cells
into 5 mL of fresh complete medium (ﬁnal volume), and incubated at
34 °C to promote doubling (within 2 weeks), and themedium replaced
weekly. BME26 cell line is derived from embryos of different ages of
Rhipicephalus microplus ticks, ﬁrst isolated in the 1980s and described
in 2008 [32].
2.3. Viability assay
BME26 cell suspension was seeded into 24-well plates (5×
105 cells/well) to a ﬁnal volume of 500 μL of complete medium and
allowed to attach. After 24-h incubation at 34 °C, chemical inhibitors
were added at the ﬁnal concentrations indicated, and whereas 0.05%
DMSO was used in negative control wells. After 24 h of treatment,
50 μL MTT prepared in serum-free medium (5 mg/mL) was added
to each well. After additional 2-h incubation, media were completely
discarded and 1 mL of acid-isopropyl alcohol (0.15% HCl in isopropyl
alcohol) was added to dissolve the formazan crystals. The mixture
was transferred to 1.5-mL tubes, spun at 6000 ×g for 15 min, and
the clear supernatant collected in new tubes for absorbance
measurement at 570 nm using quartz cuvettes in an UVmini-1240
UV–VIS spectrophotometer (Shimadzu, Japan). Unless otherwise
stated, absorbance values of control treatment were used for nor-
malization (100% viability).
2.4. RmAKT cloning
The degenerate primers, forward 5′-CARTGGACNACNGTNATYGA-3′
and reverse 5′-CCRCACATCATYTCRTACAT-3′ [33] were used to amplify
a partial AKT sequence from R. microplus egg cDNA containing the
conserved regions of AKT, the PH (pleckstrin homology) and kinase
domains, by touchdown PCR. The cycling program was as follows:
94 °C for 5 min; 95 °C for 30s, 60 °C to 50 °C (decreasing 0.6 °C at
each cycle) for 45 s, 72 °C for 1 min, 17 cycles followed by 95 °C for
30 s, 48 °C for 45 s, 72 °C for 1 min, 40 cycles; and a ﬁnal extension at
72 °C for 5 min, in 200-μL microtubes. A 793-bp PCR product was puri-
ﬁed using the Gene Clean III DNA puriﬁcation kit (QBiogene, Carlsbad,
CA, USA), and cloned into pGEM-T vector (Promega, Madison, WI,
USA) according to the manufacturer's instructions, followed by propa-
gation in Escherichia coli (DH5α strain). Recombinant plasmid DNA
was extracted using Qiagen Miniprep kit (Qiagen, Hilden, Germany)
and DNA sequencing performed by CEQ 2000 Dye Terminator Cycle
with Quick Start kit (Beckman Coulter, Inc., Fullerton, CA, USA.). To
obtain the entire cDNA sequence coding for RmAKT, 3′ and 5′-RACE
(rapid ampliﬁcation of cDNA ends) ampliﬁcations were performed
using the nucleotide sequence of the 793-bp ampliﬁed fragment.
The ﬁrst-strand cDNA for 3′-RACEwas obtained through the reaction
of SuperScript™ II Reverse Transcriptase (Invitrogen) with total RNA
and an oligo (dT) adaptor primer. The cDNA was ampliﬁed with the
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for 5′-RACE was synthesized from total RNA using the oligonucleo-
tide 5′-CCTTGAGGAACTCAAAG-3′ and reverse transcriptase enzyme,
as speciﬁed by the manufacturer (Invitrogen, Carlsbad, CA, USA). The
PCR-ampliﬁed dC-tailed cDNA was made using the abridged anchor
primer AUAP and a nested gene-speciﬁc primer 5′-CCTTGAGGAAC
TCAAAG-3′. A second nested speciﬁc primer 5′-CGACTGCTCGTCC
TTGGGC-3′ was used to perform a second PCR. The product was
cloned into pGEM-T and sequenced. Subsequently, using primers
designed from the 5′-RACE (forward primer ATGATGGAAGCGCC
ATTGGC) and 3′-RACE (reverse primer TCAGGAGAGGATGGCCT
TGCGGTC) products, the full-coding cDNA was ampliﬁed by RT-PCR
and sequenced to conﬁrm the coding region of AKT. The ampliﬁed
fragment was cloned into pGEM-T and sequenced.
2.5. Sequence analyses
Nucleotide analysis and deduced amino acid sequenceswere carried
out using a commercial software package, GENETYX-Win version 4.04
(Software development Co. LTD., Tokyo, Japan) andwith BioEdit version
7.0.9.0 [34]. The new sequence was aligned with related sequences re-
trieved from theGenbankusingCLUSTALW [35], and conserved regions
identiﬁed by the PROSITE algorithm [36]. A phylogenetic tree was
constructed using neighbor-joiningmethod [37] executed in Mega ver-
sion 5.0. module.
2.6. Double-stranded RNA (dsRNA) synthesis
A595-bpdsRNAwas designed for R.microplusAKT coding sequence.
Since R.microplus genome is not yet available, dsRNA speciﬁcity and po-
tential off-targets were estimated from similar genes in other species
with dsCheck (Drosophila melanogaster and Rattus novergicus) [38]
andDEQOR (D.melanogaster and Anopheles gambiae) [39] programs. Ol-
igonucleotide primers containing T7 promoter sequences (lower case
letters) for in vitro transcription and synthesis of dsRNA were synthe-
sized to amplify the DNA-encoding tick AKT (595 bp) (GenBank Acces-
sion number JX648548). The primer sequences were as follows:
RmAKTiT7f 5′-taatacgactcactatagggTCAGCCTGGACAACTTTGAGTTCCT
C-3′, and RmAKTiT7r 5′-taatacgactcactatagggATTTCATACATGACCACG
CCCAGC-3′. The amplicon (635 bp) generated from 1-day-old eggs
cDNA were puriﬁed by gel ﬁltration in a S-400 spin column
(Amersham) and a 2-μg aliquot was used for in vitro transcription of
dsRNA using the T7 RiboMAX™ Express RNAi System (Promega). Puri-
ﬁcation of dsRNA was performed according to manufacturer's instruc-
tions, quantitated at 260 nm and its integrity conﬁrmed by agarose
gel electrophoresis. Double-stranded RNA synthesis for RmGSK3β was
conducted as described previously [30]. The negative control for RNAi
induced gene silencing was an unrelated dsRNA designed for E. coli
β-galactosidase [kindly donated by Professor Marcos H. Sorgine,
Instituto de Bioquímica Médica (IBqM), Universidade Federal do Rio
de Janeiro (UFRJ)]. Double-stranded RNA complexes sizes: dsAKT -
635 bp, dsCN — 800 bp and dsGSK — 798 bp.
2.7. dsRNA delivery into BME26 cells
BME26 cell suspension was seeded into 24-well plates (5×
105 cells/well) to a ﬁnal volume of 500 μL of complete medium.
After 24-h incubation at 34 °C, culture medium was replaced by
200 μL of fresh medium containing 4–8 μg of dsRNA/well and the
plate was gently mixed. After additional 24-h incubation, 300 μL of
complete medium/well were added, and kept at 34 °C for 48 h [8]. Cul-
turemediumwas then fully replaced by 500 μL of fresh completemedi-
um and incubated for additional 72 h. Cells were then collected and
processed as indicated (prolonged exposure assay). Alternatively, cells
were exposed to dsRNA for 24 h in 200 μL, and then collected for assays.2.8. Conﬁrmation of gene silencing by RT-qPCR
Total RNA was extracted using Trizol Reagent (Invitrogen) from
cells exposed to dsRNA for 24 h. Two micrograms of total RNA were
reverse transcribed with High Capacity cDNA Reverse transcription
kit (Applied Biosciences). qPCR ampliﬁcations were performed with
a LightCycler 1.5 capillary platform (Roche). Serial dilutions of the
cDNA were used to construct calibration curves and ampliﬁcation
efﬁciencies (85–100%) determined for each set of primer pairs based
on the calibration curves in 10-μL reactions. The sequences of
the primers used were: 5′-GAAGTTGGCGAGTGAGGAGGA-3′ (forward),
5′-CGCGTCGAGATGCTGAACTTGT-3′ (reverse) for RmAKT (Ta=56 °C,
Amplicon 86 bp). Speciﬁc primers for R. microplus Elongation Factor
1A (Elf1A) (accession number EW679365) [40], for RmGSK3 (accession
number EF142066) [29] and for Rm40S ribosomal protein (accession
no. EW679928) [41] were the same as described previously. Relative
expression was determined using the Cp values from each run on Rela-
tive Expression Software Tool—REST [42]. Elf1A was used as reference
gene for RmAKT analysis and Rm40S was the reference gene for
RmGSK3 analysis. cDNA from BME26 not exposed to dsRNA was used
as calibrator.
2.9. Glycogen content determination
Cell lysates (in triplicate) were incubated with 1 unit
α-amyloglucosidase in acetate buffer (200 mM, pH 4.8) for 4 h at
40 °C. The reaction was stopped with phosphate buffer (100 mM,
pH 7.4). Liberated glucose was detected with a commercial kit for
glucose concentration (Glucox®, Doles) at 510 nm. Control condi-
tions (without α-amyloglucosidase) were used to determine basal
glucose level and subtracted from test conditions. Glycogen content
was determined using a standard curve submitted to the same con-
ditions [1], and normalized by total protein content. Results are
presented as mean and standard deviation from three independent
experiments.
2.10. Membrane integrity analysis
BME26 cells were plated (3×105 cell/well) over glass coverslips
placed at the bottom of 24-well plate. Cells were treated either with
dsRNA for tick AKT, or with unrelated dsRNA. After prolonged exposure
assay, BME26 cells were directly stained by adding Hoechst 33342
(0.4 μg/mL, ﬁnal concentration) for 5 min, and then propidium iodide
(2 μg/mL, ﬁnal concentration) for additional 2 min. Incubations at
room temperature were performed protected from light. Well content
was discarded, coverslips were washed with PBS and mounted over
glass slides with 5 μL of glycerol. Cells were observed under ﬂorescence
microscope (model Eclipse 80i, Nikon, Japan), and pictures were
obtained at 400× magniﬁcation.
2.11. Protein determination
Total protein was determined according to Bradford [43], using
bovine serum albumin as standard.
2.12. RmAKT expression during embryogenesis
Total RNA was extracted from R. microplus eggs on different days
after oviposition with TRIZOL reagent (Invitrogen) according to the
manufacturer's protocol. One microgram of total RNA was converted
into complementary DNA with the High Capacity cDNA Reverse tran-
scription kit (Applied Biosciences). Quantitative PCR analysis was
performed using 200 ng of cDNA in 10-μL reactions in a LightCycler
platform, as described above. Relative expression determination was
performed as described earlier, using one-day-old eggs as calibrators,
Fig. 1. Inhibition of AKT or GSK3 activity promotes different effects on BME26 cells viabil-
ity. BME26 cells were treated for 24 h in the presence of different concentrations of AKT
inhibitor 10-DEBC (A) or GSK3 inhibitor alsterpaullone (B) in complete medium in tripli-
cate wells. Cell viability was not altered by alsterpaullone exposure (4–400 nM). Treat-
ment with 10-DEBC (0–96 μM) decreased cell viability in a concentration-dependent
fashion. Cell viability was measured by MTT assay, and the results were normalized
against control exposed to vehicle alone (0.05%DMSO). Gray line indicates the concentra-
tion interval to be used for further analysis. Insert: IC50 of 48 μM was determined for
10-DEBC treatment. Plots represent mean±SD from at least two independent experi-
ments. ***=pb0.001, compared to control treatment.
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different experiments performed in triplicates (independent samples).
2.13. Ultraviolet light exposure
BME26 cells treated with dsRNA for tick GSK3 were exposed to UV
light (254 nm) within a distance of 54 cm, for 8 min in order to induce
cell death [44]. After treatment, cellswere incubated for 24 h and viabil-
ity determined by the MTT assay. Values were normalized with cells
not treated with dsRNA and comparisons done with treatment with
unrelated dsRNA.
In other experiments, BME26 cellswere incubatedwith alsterpaullone
or vehicle alone (0.05%DMSO) for 60 min at 34 °C prior to UV light expo-
sure (15 min), and cell viability was determined by MTT after additional
24-h incubation. Viability values were normalized by those obtained for
cells in vehicle alone not exposed to UV.
2.14. Statistical analysis
Non-parametric analysis was used in glycogen and viability com-
parisons between inhibition/knock down of AKT and GSK3. Results
for AKT expression were analyzed by one-way ANOVA. The GraphPad
Prism 5.03 Software was used in all analyses.
3. Results
3.1. AKT or GSK3 inhibition has different effects on BME26 cell viability
To examine the effects of AKT inhibition on viability, BME26 cells
were treated with different concentrations of 10-DEBC (AKT inhibitor)
or vehicle alone (0.05% DMSO) for 24 h. Cell viability as determined
byMTT, which revealed that AKT inhibitionwith 10-DEBC decreased vi-
ability in a dose-dependent manner within the range of 24 and 96 μM
(Fig. 1A). Cell viability was slightly altered up to 24 μM 10-DEBC, but
it signiﬁcantly decreased in the presence of 48–96 μM 10-DEBC. The
IC50 value for 10-DEBC inhibitor was determined to be approximately
48 μM (insert). In order to determine the effects of 10-DEBC on glyco-
gen content, we used concentrations lower than the corresponding
IC50. Alsterpaullone, a chemical inhibitor of GSK3, had no signiﬁcant
effect on BME26 viability, when used in concentrations ranging from 4
to 400 nM (Fig. 1B). Treatment with PI3K inhibitors LY294002 and
wortmannin mildly affected BME26 viability (Supplementary Fig. 2).
3.2. Effects of AKT and GSK3 inhibition on BME26 glycogen content
The participation of AKT and GSK3β in glycogen metabolism in
BME26 cells was determined by culturing them in the presence of in-
hibitors in the growth medium. Glycogen content decreased 30.4%
and 36.5% in cells exposed to 6 and 12 μM 10-DEBC, respectively, com-
pared to cells treatedwith vehicle alone (0.05%DMSO) (Fig. 2A). On the
other hand, cells treated with 1 μM alsterpaullone (GSK3 inhibitor)
showed a nearly 50% increase in glycogen level (Fig. 2B).
3.3. Cloning and sequence analysis of RmAKT
PCR with egg cDNA yielded a fragment that encodes an AKT-like
protein sequence when searched against protein sequences in
the NCBI. Full-length tick AKT cDNA (1584 bp) was determined from
sequence data obtained by cloning RACE PCR products and from
sequences available in nucleotide database. The deduced RmAKT
amino acid sequence (527 aa) was aligned with homologous proteins
with ClustalW (Supplementary Fig. 1). ScanProsite analysis showed
that the Pleckstrin Homology (PH) domain ranges from positions 39
to 141, the Serine/Threonine (Ser/Thr) kinase domain is between posi-
tions 180 and 437, and a hydrophobic motif is present from positions501 to 506. The putative phosphorylation sites are also conserved at
Thr336 and Ser505 residues.
RmAKT and amino acid sequences of related proteins were
subjected to phylogenetic analysis, and a tree was constructed (Fig. 3).
The phylogeny consists of two protein clades: one that includes
RmAKT and other AKTs from arthropods, and one bearing mammalian
AKTs. In addition, the RmAKT sequence pairs with AKT homologue
from H. longicornis, with high bootstrap values.
3.4. Effects of RmAKT and RmGSK3 silencing on BME26 cells
Possible accidental targets of AKT and GSK3 silencing by RNAi
were selected based on orthologous sequences of D. melanogaster
and C. elegans, since the entire R. microplus genome is unavailable.
Both DEQOR and dsCheck analyses showed high efﬁciency and spec-
iﬁcity of the iRNAs, and revealed that the chances of non-target inhi-
bition would be signiﬁcantly lower in comparison with the desired
targets (data not shown).
The RNAimediated gene silencing for AKT andGSK3β in BME26 cells
was greater than 70% (Fig. 4A and B), as determined by relative expres-
sion analysis using RT-qPCR within the ﬁrst 24 h of dsRNA exposure.
Additionally, glycogen content in AKT silenced cells decreased by ap-
proximately 30% (Fig. 5A). On the other hand, glycogen content was in-
creased in cells silenced for GSK3β by almost 50% (Fig. 5B). Glycogen
Fig. 2. Glycogen content alteration by inhibition of AKT or GSK3. BME26 cells were
treated with increasing concentrations of 10-DEBC for 24 h (A) or alsterpaullone
for 2 h (B). Glycogen content was enzymatically determined (see Methodology item 2.9).
The plots represent mean±SD from three independent experiments. **=pb0.01, com-
pared to control (DMSO) treatment.
Fig. 3. Phylogenetic analysis of AKT from different species. Phylogenetic tree
representing the sum of evolutionary distances for branches (0.05) using Muscle
tool in 5.0 MEGA software. NCBI sequences used for comparison analysis were
Haemaphysalis longicornis BAK26531.1 (Hlon), Bombyx mori: ABY50539.1 (Bmori),
Drosophila melanogaster: NP_732114.1 (Dmel), Anopheles gambiae: EAA03708.5
(Agam), Aedes aegypti: AAP37655.1 (Aaeg), Apis mellifera: XP_396874.4 (Amel),
Tribolium castaneum: XP_968049.2 (Tcas), Caenorhabditis elegans: NP_001023646.1
(Cele), Homo sapiens 1: AAL55732.1 (Hsap1), Homo sapiens 2: AAI20996.1 (Hsap2),
Homo sapiens 3: AAD24196.1 (Hsap3), Bos taurus 1: CAA43371.1 (Btau1), Bos taurus
2: DAA19835.1 (Btau2), Bos taurus 3: DAA21408.1 (Btau3) and Danio rerio:
NP_937789.1 (Drer).
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posure assay.
BME26 cells silenced for AKT exhibited a near 30% reduction in cell
viability, as determined by theMTT assay (Fig. 6A). It was also observed
that cells treatedwith dsAKTdouble-stainedwith propidium iodide and
Hoechst 33342 (pink nuclei in Fig. 6C) at higher intensity, compared to
cells exposed to the unrelated dsRNA (Hoechst 33342 blue stained
nuclei in Fig. 6B).
BME26 cells were exposed to UV light for 8 min and cell viability
determined by the MTT assay after 24 h (Fig. 7A). There was no sig-
niﬁcant difference between cells treated with test dsRNA (black bar)
and those treated with unrelated control dsRNA (white bar). Howev-
er, cells previously silenced for GSK3β showed a signiﬁcant increase
(17%) in cell viability (dashed bars). Chemical inhibition of GSK3 by
alsterpaullone treatment prior to UV light exposure also protected
BME26 viability (Fig. 7B) in a dose-dependent manner. Cells treated
with 1 μM alsterpaullone were as viable as those not exposed to UV.
Fig. 8 is a schematic representation of the proposed model of the
conserved role of the AKT/GSK3 axis in cell viability and glycogen
metabolism in R. microplus tick embryo cell line BME26.
3.5. RmAKT is transcribed during tick embryogenesis
In tick embryos of different ages, the AKT gene was found to be
expressed at the highest level in day 1 embryos, at signiﬁcantly lesser
amounts in day 3 embryos, and thereafter remained unaltered until
day 18 (Fig. 9).4. Discussion
Here, we describe an important signal transduction axis that inte-
grates our previous knowledge about the PI3K/AKT signaling pathway
in BME26 cells and the importance of GSK3 in tick embryogenesis
[26,30]. The importance of AKT signaling has been demonstrated in a
number of organisms, and supports a conserved role in the regulation
of cell metabolism [45]. It is strongly associated with some types of
human cancer, and acts mainly by increasing the inhibition of
pro-apoptotic components and improving energy metabolism [46].
AKT kinase is an important downstream effector of the PI3K pathway
that can be activated by growth factors, cytokines and peptides related
to the insulin family [11,12]. Remarkably, dysfunctional AKT activity has
emerged as a promising target in the development of drugs against
some forms of cancer [47].
In D. melanogaster, AKT activity has been shown to be at the core of
nutrient sensing mechanisms that incorporate hormonal and growth
factors pathways, and processes associated with reproduction [45,48].
More recently, activation of AKT signaling in Anopheles stephensi
mosquitoes was shown to reduce malaria parasite infectivity [49].
Moreover, Bombyx mori AKT has been shown to be phosphorylated fol-
lowing stimulation by bombyxin, an endogenous insulin-like peptide,
as well as by dietary intake [50].
AKT regulation during glycogen metabolism has largely been
deduced from correlating the phosphorylation status of both AKT (ac-
tive upon phosphorylation at Ser Thr residues) and GSK3 (is inhibited
upon phosphorylation at Ser9/21 by AKT) [19,31,51]. In the present
study, we show that glycogen distribution is tilted in opposite direc-
tions when either AKT or GSK3β is genetically silenced (Fig. 5). Our
data also strongly suggest that GSK3 is a downstream target of AKT reg-
ulation during glycogenmetabolism in tick cells (Fig. 8). Chemical inhi-
bition of either AKT or GSK3 (Fig. 2) promoted opposing effects in
glycogen content, which reinforces our observations. Interestingly,
even though cells treated with low concentrations of alsterpaullone
exhibited an increase in glycogen content, cell viability was not altered
within the range of 4 and 400 nM(Figs. 1B and 2B). On the other hand, a
Fig. 5. Glycogen content is differently affected by AKT and GSK3 gene silencing. BME26
cells were treated with dsRNA for AKT (A) or GSK3 (B) genes independently, and gly-
cogen content was enzymatically determined (see Methodology) by the end of the
prolonged exposure assay. Glycogen content was decreased upon AKT silencing but in-
creased by GSK3 silencing. The plots represent mean±SD from three independent ex-
periments in triplicates. *=pb0.05.
Fig. 4. Conﬁrmation of RNAi mediated gene silencing by RT-qPCR in BME26 cells.
BME26 cells were treated with dsRNA for AKT (A) or GSK3 (B) genes independently,
and relative transcription was determined by RT-qPCR. AKT silencing was conﬁrmed
24 h after dsRNA treatment. GSK3 silencing was conﬁrmed at the end of the prolonged
exposure assay. The plots represent mean±SE from three independent experiments.
*=pb0.05, with respect to cells treated with unrelated dsRNA (dsCN), and using
Elf1A (A) or 40S (B) as reference genes to determine relative transcription using the
Pfafﬂ (2001) method.
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concentrations below the IC50 determined (Figs. 1A and 2A). These data
support a prevalent role of AKT in the regulation of BME26 cell survival.
Besides the suggested roles of AKT/GSK3 pathway in cell metabo-
lism and survival, the data presented here also support its participa-
tion in vivo during R. microplus embryogenesis (Fig. 9). In such
context, tick embryogenesis emerges as a tempting target in identi-
fying novel pathways whose inhibition would have signiﬁcant im-
pact on tick physiology [52,53]. Studies using neuronal cell lines
depict a differential modulation of AKT/GSK3β pathway in the regula-
tion of apoptotic and cytoprotective signaling responses [54]. Similarly,
in the current study, AKT knockdown resulted in reduced viability of
BME26 cells (Fig. 6A) and disturbed cell permeability (Fig. 6B and C),
which strongly suggests that an apoptotic pathway may also occur in
BME26 cells. However, the type of cell death promoted by AKT knock-
down in BME26 cells was not the focus of the present work. Previous
studies reported programmed cell death in adult Rhipicephalus
sanguineus [55,56], R. microplus [57] and Dermacentor variabilis [58]
ticks. The observations that both AKT (Fig. 9) and GSK3β [29] are
expressed during tick embryogenesis do not rule out the possibility
that AKT/GSK3β signaling exerts similar importance in vivo, and at
other life stages.
The results presented here further suggest that GSK3β is also in-
volved in cell survival in addition to glycogen metabolism in BME26
cell line. UV light exposure is thought to induce cell death mainly
through the deleterious effects on DNA, which then compromise some
protein functions [59]. GSK3β knocked-down BME26 cells challengedby UV exposure exhibited extended longevity as determined by MMT
assay, in comparison with controls (Fig. 7A). Moreover, GSK3β inhibi-
tion prior to UV exposure promoted a protective effect for cell viability
(Fig. 7B). These results support the importance and functional conser-
vation of GSK3β activity for BME26 cell line. In vitro studies in mammal
cell culture demonstrate that GSK3β inhibition attenuates or fully abro-
gates apoptosis [60]. Taken together with ﬁndings from other studies,
these observations place GSK3β as a promoter of apoptosis due
to inhibition of prosurvival transcription factors and facilitation of
proapoptotic transcription factors [61]. Such protective effect of delet-
ing GSK3β is also focus of developing novel radioprotectors. The use
of GSK3β inhibitors in animals undergoing radiotherapy were shown
to protect normal tissues from radiation-induced apoptosis and attenu-
ate neurocognitive dysfunction resulting from cranial irradiation [62].
Conversely, overexpression of wild-type GSK3β induces apopto-
sis in various cell types in culture, and speciﬁc inhibition of GSK3β
ameliorates apoptosis [63,64]. GSK3 inhibition was shown to inhibit
apoptotic cell death in neuroblastoma cell line SH-SY5Y upon treat-
ment with ﬁpronil [65]. More recently, GSK3β inhibitors have also
been used in pharmacologic prophylaxis to protect normal tissues
during radiotherapy in cancer patients, due to its key role in regula-
tion of radiation-induced apoptosis [62]. Previous observations of
GSK3β role during tick and mosquito embryogenesis support a strict
control in respect to glycogen metabolism and mobilization [3,29].
Additionally, GSK3β activity was recently shown to greatly inﬂuence
tick oviposition and normal embryo development [30].
Targeting ISP components has been proposed for Giardia intestinalis
by selective inhibition of PI3K [66]. In insects, ISP regulates growth, nu-
tritional status and reproduction. Inhibition of PI3K mimics the effects
of starvation and reduction of Insulin Receptor signaling reduces
Fig. 6. AKT silencing effects on cell viability and membrane permeability. BME26 cells
were silenced for AKT using the prolonged exposure assay, and then cell viability was
determined by the MTT assay (A). Loss of membrane integrity was also detected in
cells stained with Hoechst 33342/Propidium iodide observed with pink nuclei (aster-
isks) under ﬂuorescence microscope (Nikon 80i). Hoechst 33342 permeable cells
were stained with blue nuclei (arrows). Compare pink signal in B and C. The plot rep-
resents mean±SD from two independent experiments in triplicates. ***=pb0.001,
compared to control treatment (B, unrelated dsRNA). Magniﬁcation: 400×. Pictures
are representative of 2 independent experiments in triplicates.
Fig. 7. GSK3 blockade effects on cell viability after death inducing UV exposure. A:
BME26 cells were silenced for GSK3 using the prolonged exposure assay, and then ex-
posed to UV light for 8 min. Cell viability was determined by the MTT assay 24 h after
UV exposure, and normalized by the viability of cells not treated with dsRNA (black
bar). White bar - unrelated dsRNA, Dashed bar — GSK3 gene silenced cells. The plot
represents mean±SD. *=pb0.05. B: BME26 cells not treated with dsRNA were incu-
bated with alsterpaullone (Alst) or vehicle alone (0.05% DMSO, black bar) by 60 min
at 34 °C prior to U.V. light exposure (15 min), and after additional 24 h incubation
cell viability was determined by MTT assay. Viability values were normalized by
those obtained for cells in vehicle alone not exposed to U.V. Plots represent mean±
S.D. from 3 independent experiments in triplicate. Asterisks represent signiﬁcant dif-
ferences from treatment with vehicle alone (**=pb0.1; ***=pb0.01). Paragraph sym-
bol indicates signiﬁcant differences from treatment with vehicle and U.V. exposure
(§=pb0.5; §§§=pb0.01).
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ciﬁc inhibitors for or antisera against ligand binding domains of Insulin
Receptor blocks glucose uptake [67]. These observations suggested that
designed inhibitors capable of blocking the binding site of Insulin recep-
tor or inhibiting downstream signals could starve theworms. The grow-
ing reports on the insulin signaling pathway present a new opportunity
on the emerging need for expertise in arachno-entomology [68].Characterizing gene functions by RNAi silencing has become an es-
sential procedure for tick biologists [69]. RNAi using dsRNA was suc-
cessfully performed on BME26 cells with a transcription reduction
over 70%, being detected 24 h post exposure (Fig. 4). Past reports on
gene silencing in BME26 cells focused on the mechanisms underlying
RNAi pathway in ticks [70] and to determine genes that are differential-
ly expressed in response to infection with Anaplasma marginale [8].
Moreover, the majority of studies that have reported using RNAi in
tick cell lines have focused on tick-borne pathogen pathology and the
function of genes either in vector-pathogen relationships or as candi-
date targets for anti-tick control methods [71]. In the present work,
we extend the application of RNAi in tick cell lines to examine the
AKT/GSK3β axis. Our data suggest that such a pathway is conserved in
ticks and tick cell lines in a way that integrates both glycogen metabo-
lism and cell survival (Fig. 8). Both processes are essential for proper
embryo development, and cannot be ignored in adult life stages of
ticks. Further studies are necessary to better understand the mecha-
nisms involved on the regulation of cell survival in ticks. The correlation
between signal transduction andmetabolic pathways emerges as an at-
tractive area for tick cell line research, andmay be extrapolated to other
tick life stages.
Although mammalian and arthropod AKT proteins have similar
biochemical properties, sequence and phylogenic analyses coupled
Fig. 8. Schematic model showing the conserved role of the AKT-GSK3 axis on cell viability and glycogenmetabolism in BME26 cells. BME26 cells were treated as indicated by the left side
of the white boxes in order to block the activity of either AKT or GSK3. The effects on cell viability and glycogen content are indicated on the right side of the white boxes. : increase,
: decrease, blunt arrow head: direct inhibition, dashed arrow: multi step signal transduction, : GSK3 knocked down cells exposed to U.V., PI3K: phosphatidylinositol 3-OH kinase.
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(Fig. 3). Therefore, it could be possible to exploit these differences in
the design of new inhibitors that selectively impair the arthropod vector
while causing minimal effects on the mammalian host, a prerequisite
for commercials acaricides. With existing acaricidal products rapidly
losing their efﬁcacy, there is urgent need to explore alternative control
methods against ticks. The discovery and characterization of physiolog-
ical pathways could lead to novel drug targets, candidate drugs or anti-
gens while at the same time reveal new processes that are essential to
ticks' complex physiological adaptations.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbagen.2012.12.016.Acknowledgements
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